Advertisement

Topics

Alcyone Lifesciences Enters Into A Feasibility Study Agreement With Pfizer To Evaluate s Proprietary Pulsar Advanced Intrathecal Precision Delivery Platform Technology For Use In Gene Therapy Targeting Central Nervous System Disorders

20:00 EDT 28 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Alcyone Lifesciences Enters Into A Feasibility Study Agreement With Pfizer To Evaluate s Proprietary Pulsar Advanced Intrathecal Precision Delivery Platform Technology For Use In Gene Therapy Targeting Central Nervous System Disorders

NEXT ARTICLE

More From BioPortfolio on "Alcyone Lifesciences Enters Into A Feasibility Study Agreement With Pfizer To Evaluate s Proprietary Pulsar Advanced Intrathecal Precision Delivery Platform Technology For Use In Gene Therapy Targeting Central Nervous System Disorders"

Advertisement
Quick Search
Advertisement
Advertisement